期刊文献+

拉西地平的时间药理学对老年非杓型高血压患者的治疗作用 被引量:3

The therapeutic effects of chronopharmacology of lacidipine on non-dipper hypertension in elderly patients
下载PDF
导出
摘要 目的探讨不同时间服用钙拮抗剂拉西地平对老年非杓型高血压患者血压的影响。方法筛选出未使用二氢吡啶类钙拮抗剂≥4周的老年非杓型高血压患者66例,随机分为拉西地平晨起服药组(32例)和晚上服药组(34例),4 mg/d,共治疗48周。患者治疗前后分别进行24 h动态血压监测的检查。结果晨起服药组患者昼间收缩压迭标率为46.9%,晚上服药组为38.2%,两组比较差异无统计学意义(P>0.05)。晨起服药组患者夜间收缩压达标率为28.1%,晚上服药组为67.6%,两组比较差异有统计学意义(P<0.01)。晨起服药组患者由非杓型纠正为杓型18.8%,晚上服药组47.1%,两组比较差异有统计学意义(P<0.01)。结论对于非杓型老年高血压患者,拉西地平可以较好地纠正夜间的高负荷血压,提高夜间血压达标率。 Objective To investigate the effect of calcium antagonist lacidipine administered at different time on blood pressure(BP) in elderly non-dipper hypertensive patients. Methods Sixty six elderly patients with non-dipper hypertension treated with dihydropyridines(calcium antagonists) for ≥4 weets were divided randomly into 2 groups:lacidipine(4 rag/d) morning dosing group(32 patients) and evening dosing group(34 patients) , and treated for 48w. Results 46. 90/00 of the morning group achieved the target day-time SBP,while 38.2% of the evening group achieved the target SBP, with no significant difference between the two groups (P 〉 0. 05). The morning group achieved the target night-time SBP in 28.1 % of the patients,while evening group achieved the target SBP in 67.6% ,with significant difference between the two groups (P 〈 0.01). Change of circadian rhythm from non-dipper to dipper was found in 18. 8% in morning group versus 47.1% in the evening group,and there was significant difference between the two groups (P〈0.01). Conclusion Compared with morning program,evening program might be more effective in decreasing the high night BP load and changing non-dipper to dipper pattern.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2009年第2期99-101,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 高血压 抗高血压药 药理学 时间治疗学 钙通道阻滞剂 hypertension artihypertensive agents pharmacology chronotherapeutics calciumchannel blockers
  • 相关文献

参考文献5

二级参考文献8

  • 1郭晓华,李俊萍,郑玉云,孙淑艳,陈丽珠.拉西地平治疗原发性高血压的疗效观察[J].高血压杂志,2006,14(4):310-311. 被引量:13
  • 2[2]Celermajer DS,Sorensen KE,Gooch VM,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of aterosclerosis[J].Lancet,1992,340:1111-1115.
  • 3[3]Pitt B,Byington RP,Furberg CD,et al.Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events[J].Circulation,2000,102:1503-1510.
  • 4[4]SimonA,Gariepy J,Moyse D,et al.Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes[J].Circulation,2001,103:2949-1954.
  • 5Lindholm LH, Tcherdskoff P, Zanchetti A. Safety profile of lacidipine:update from a clinical trials database. Drags, 1999,57 (Suppl) : S27-S29.
  • 6Armas PM,Armas HM, Hemandez HR,et al. Effect of lacidipine and nifedipine GIIS on platelet function in patients with essential hypertensio. J Hum Hypertens,2000,14(Suppl) :S91-S95.
  • 7刘国仗,胡大一,陶萍,诸骏仁,郭林妮,郭静萱,游凯.心血管药物临床试验评价方法的建议[J].中华心血管病杂志,1998,26(1):5-11. 被引量:1440
  • 8胡晋红,杨樟卫.药物经济学的不同研究方法及相互比较[J].中国临床药学杂志,2000,9(5):318-320. 被引量:7

共引文献8

同被引文献306

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部